Delivery Order SPE2DB22D3501-SPE2DB25FXD66
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250ml quantities, with a ceiling value of $1,442.97. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,736.37 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract, executed on June 18, 2025, with an ultimate completion date of June 20, 2025, utilizes firm fixed price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger federal...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml quantity with a ceiling value of $1,125.28. The award is unset-aside and competitively awarded under a firm fixed price structure, with an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 150 mg tablets (100-count units) with a ceiling value of $2,169.26. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified vendor. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $34.77K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of May 13, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, valued at $3,670.92 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The delivery order, which is non-competitive and represents a child contract, carries an ultimate completion date of September 11, 2025. This award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $3,945.25 from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025. This firm fixed price contract, with an ultimate completion date of September 19, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp on August 16, 2025, for pharmaceutical and medical supply delivery. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The award was made through open...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for pharmaceutical and medical supply products valued at $41,277.84. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXD66Delivery Order
On September 3, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,791.77 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order represents a small-value transaction within AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts supporting federal healthcare systems. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, and the company currently serves critical customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/3/25 |